Instructions for Nicergoline lyophilisate for solution preparation
English product name
Nicergoline
Release Form
lyophilizate d/r-fit d/injecz. 4 mg: amp. 5 pcs. per set with solvent
Description Nicergoline
Lyophilizate for preparation of solution for injection in the form of a porous mass or white powder, odorless.
1 amp.
nitergolin 4 mg
Auxiliary substances: wine acid - 1.04 mg, lactose monohydrate (milk sugar) - 30 mg.
Solvent: 0.9% sodium(5 ml) sodium p-r.
4 mg - glass ampoules (5) - contoured box packaging (1) complete with solvent (amp). 5 pcs. in the package of the contour cell) - cardboard packs.
ATC codes
C04AE02 Nicergoline
Clinical-pharmacological groups / Group affiliation
Alpha Adrenolocator
Active substance
nitergolin
Pharmaco-therapeutic group Nicergoline
Alpha Adrenolocator
Storage Conditions
List B. Store in a place not accessible to children, protected from light at a temperature not higher than 10 ° C.
Best before date
The shelf life is 3 years.
Pharmacological effect Nicergoline
Alpha-adrenoblocker is a synthetic derivative of ergot alkaloids, with bromosubstituted nicotinic acid residue attached. It has vasodilating (including in relation to the brain arteries) effect. Improves microcirculation.
Testimony Nicergoline
Cerebral circulation disorders (arteriosclerosis of cerebral vessels, thrombosis and thromboembolia of cerebral arteries, cerebral ischemia, post-traumatic encephalopathy, psychoorganic syndrome);
vertigo;
migraine;
vascular disorders of the peripheral circulatory system (organic and functional);
Arteriopathy of the limbs;
Obliterating endarteritis;
Rayno disease;
diabetic angiopathy;
Dystrophic corneal diseases;
diabetic retinopathy;
ischemic neuropathy of the optic nerve.
Method of use, course and dosage Nicergoline
V/m, v/v and intra-arterial, having previously dissolved 0.9% chloride sodium solution, v/m - two to four mg twice per day.
B/B drip - 4-8 mg per 100 ml of saline solution of sodium chloride (if necessary, the introduction can be repeated several times a day).
Intra-arterial - 4 mg per 10 ml saline solution of sodium chloride for two minutes.
The healing effect develops gradually. The course of treatment is not less than 2 months.
- Nosology Nicergoline (ICD codes)
- F07
- Personality and behavioural disorders caused by disease, damage or brain dysfunction
- G43
- Migraine
- G45
- Transitory cerebral ischemic attacks [attacks] and related syndromes
- G45.0
- Vertebrobasilar arterial syndrome
- H31.1
- Degeneration of the vascular lining of the eye
- H31.2
- Hereditary vascular ocular dystrophy
- H35.0
- Background retinopathy and retinal vascular changes
- H36.0
- Diabetic retinopathy
- H81
- Vestibular function disorders
- H81.0
- Ménière's disease
- I63
- Brain infarction
- I67.2
- Cerebral atherosclerosis
- I67.4
- Hypertensive encephalopathy
- I69
- Effects of cerebrovascular disease
- I73.0
- Reynaud syndrome
- I73.1
- Clotting Thrombangitis [Berger's disease]
- I73.9
- Peripheral vascular disease unspecified (including interspersed lameness, arterial spasm)
- I79.2
- Peripheral angiopathy for diseases classified in other headings (including diabetic angiopathy)
